FundedIQ
Health Care

Aer Therapeutics: Funding, Investors & Team (Oct 2026)

Aer Therapeutics is a biopharmaceutical company that is currently in the clinical stage of development. Their goal is to develop a treatment method for lung diseases that involve excessive amounts of mucus and mucus plugs. The company has a specific focus on addressing respiratory disorders that are challenging to treat, such as cystic fibrosis, COPD, and asthma.

aertherapeutics.com LinkedIn Raleigh, United States 1-10 employees
Health Care Medical Therapeutics
Total raised
$51.9M
Rounds
2
Latest
Series A
Apr 2023

Aer Therapeutics has raised $51.9M across 2 funding rounds on record, the most recent a Series A of $36.0M announced in Apr 2023.

That round is above the $4.9M median round size for Health Care companies tracked on FundedIQ over the last two years.

Aer Therapeutics Company Profile and Key Stats

Total funding raised
$51.9M
across 2 rounds on record
Funding rounds on record
2
Latest funding round
Series A
$36.0M in Apr 2023
Employees
1-10
reported band
Headquarters
Raleigh, United States

Latest funding round on record: Apr 2023.

Aer Therapeutics Funding Rounds

Date
Round
Amount
Series A
$36.0M
Undisclosed round
$15.9M

Aer Therapeutics raised $15.9M in an undisclosed round announced in Dec 2022.

4 months later, a Series A of $36.0M was announced in Apr 2023.

Aer Therapeutics Founders and Leadership Team

Name
Role
Contact
John Fahy
Founder
Locked
Jim Shaffer
CEO
—

Contact details for the Aer Therapeutics team: 1 of 2 have an email address on file.

Start 14-day free trial →

Aer Therapeutics Funding Compared to Other Health Care Startups

Segment
Companies
Median round
3,659
$4.9M
30,234
$7.6M
8,558
$15M

Aer Therapeutics' latest round of $36.0M is above the median round in Health Care. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Aer Therapeutics in Health Care and Raleigh

Companies Similar to Aer Therapeutics

Using technology and the best professionals, Wally, a membership-based dental care service, offers proactive,…

Series A $25.0M

PreciseDx is a unique Cancer Risk Stratification company that offers personalized risk information by…

Undisclosed round $3.7M

General Medicine provides a convenient and straightforward way to access top-quality healthcare services with…

Series B $120M

Forty million men in the US and over 500 million worldwide suffer from urinary obstruction related to benign…

Series D $52.0M

SedMed provides medical devices that support safer toileting transfers and help prevent falls for individuals…

Undisclosed round $4.0M

Aptatek is developing cutting edge technologies for portable disease management devices that will improve…

Undisclosed round —

Flow Medical offers multi-function catheters to aid in the diagnosis and treatment of venous thromboembolic…

Undisclosed round $150k

Light Wave Dental Management offers management services for high-quality dental offices in Virginia.…

Undisclosed round $1.0M

For health care systems and payers focused on improving maternal outcomes and health equity, our product is a…

Seed $250k

Tempo Therapeutics creates materials that are designed for regenerative medicine, with a focus on being…

Undisclosed round $14.5M

Vibronix was established by Dr. Ji-Xin Cheng and Dr. Pu Wang at Purdue University with the goal of offering…

Series B $14.9M

People with chronic diseases can live their best lives thanks to Vheda Health. We concentrate on three areas…

Undisclosed round $47.0M

Aer Therapeutics Funding FAQs

What does Aer Therapeutics do?

Aer Therapeutics is a biopharmaceutical company that is currently in the clinical stage of development. Their goal is to develop a treatment method for lung diseases that involve excessive amounts of mucus and mucus plugs. The company has a specific focus on addressing respiratory disorders that are challenging to treat, such as cystic fibrosis, COPD, and asthma.

How much funding has Aer Therapeutics raised?

Aer Therapeutics has raised $51.9M across 2 rounds on record. The most recent is a Series A of $36.0M announced in Apr 2023.

When did Aer Therapeutics last raise funding?

Aer Therapeutics' most recent funding round on record is a Series A of $36.0M, announced in Apr 2023.

Who founded Aer Therapeutics?

FundedIQ lists John Fahy (Founder) at Aer Therapeutics.

Who is the CEO of Aer Therapeutics?

Jim Shaffer is listed as CEO at Aer Therapeutics.

Where is Aer Therapeutics headquartered?

Aer Therapeutics is based in Raleigh, North Carolina, United States.

How many employees does Aer Therapeutics have?

Aer Therapeutics is in the 1-10 employee band.

How does Aer Therapeutics' funding compare to other Health Care startups?

Aer Therapeutics' latest round of $36.0M is above the $4.9M median round size for Health Care companies on FundedIQ across 3,659 tracked companies over the last two years.

About FundedIQ's Aer Therapeutics Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aer Therapeutics is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.